Rajshri M Gartland1,2, Jordan P Bloom3, Sareh Parangi3, Richard Hodin3, Courtney DeRoo4, Antonia E Stephen3, Vinod Narra3, Carrie C Lubitz3, Elizabeth Mort5,6. 1. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. rgartland@mgh.harvard.edu. 2. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Massachusetts General Physicians Organization, Boston, MA, USA. rgartland@mgh.harvard.edu. 3. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 4. CRICO Risk Management Foundation, Boston, MA, USA. 5. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Massachusetts General Physicians Organization, Boston, MA, USA. 6. Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Given their profound emotional, physical, and financial toll on patients and surgeons, we studied the characteristics, costs, and contributing factors of thyroid and parathyroid surgical malpractice claims. METHODS: Using the Controlled Risk Insurance Company Strategies' Comparative Benchmarking System database, representing ~30% of all US paid and unpaid malpractice claims, 5384 claims filed against general surgeons and otolaryngologists from 1995-2015 were reviewed to isolate claims involving the surgical management of thyroid and parathyroid disease. These claims were studied, and multivariable regression analysis was performed to identify factors associated with plaintiff payout. RESULTS: One hundred twenty-eight thyroid and parathyroid surgical malpractice claims were isolated. The median time from alleged harm event to closure of a malpractice case was 39 months. The most common associated complications were bilateral recurrent laryngeal nerve (RLN) injury (n = 23) and hematoma (n = 18). Complications led to death in 18 cases. Patient payout occurred in 33% of claims (n = 42), and the median cost per claim was $277,913 (IQR $87,343-$783,663). On multivariable analysis, bilateral RLN injury was predictive of patient payout (OR 3.58, p = 0.03), while procedure, death, and surgeon specialty were not. CONCLUSION: Though rare, malpractice claims related to thyroid and parathyroid surgery are costly, time-consuming, and reveal opportunities for early surgeon-patient resolution after poor outcomes.
BACKGROUND: Given their profound emotional, physical, and financial toll on patients and surgeons, we studied the characteristics, costs, and contributing factors of thyroid and parathyroid surgical malpractice claims. METHODS: Using the Controlled Risk Insurance Company Strategies' Comparative Benchmarking System database, representing ~30% of all US paid and unpaid malpractice claims, 5384 claims filed against general surgeons and otolaryngologists from 1995-2015 were reviewed to isolate claims involving the surgical management of thyroid and parathyroid disease. These claims were studied, and multivariable regression analysis was performed to identify factors associated with plaintiff payout. RESULTS: One hundred twenty-eight thyroid and parathyroid surgical malpractice claims were isolated. The median time from alleged harm event to closure of a malpractice case was 39 months. The most common associated complications were bilateral recurrent laryngeal nerve (RLN) injury (n = 23) and hematoma (n = 18). Complications led to death in 18 cases. Patient payout occurred in 33% of claims (n = 42), and the median cost per claim was $277,913 (IQR $87,343-$783,663). On multivariable analysis, bilateral RLN injury was predictive of patient payout (OR 3.58, p = 0.03), while procedure, death, and surgeon specialty were not. CONCLUSION: Though rare, malpractice claims related to thyroid and parathyroid surgery are costly, time-consuming, and reveal opportunities for early surgeon-patient resolution after poor outcomes.
Authors: David M Studdert; Michelle M Mello; Atul A Gawande; Tejal K Gandhi; Allen Kachalia; Catherine Yoon; Ann Louise Puopolo; Troyen A Brennan Journal: N Engl J Med Date: 2006-05-11 Impact factor: 91.245
Authors: Charles M Balch; Michael R Oreskovich; Lotte N Dyrbye; Joseph M Colaiano; Daniel V Satele; Jeff A Sloan; Tait D Shanafelt Journal: J Am Coll Surg Date: 2011-09-03 Impact factor: 6.113
Authors: Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky Journal: Thyroid Date: 2016-01 Impact factor: 6.568
Authors: Rajshri M Gartland; Jordan P Bloom; Zhi Ven Fong; Courtney DeRoo; Kathy Dwyer; Gene Quinn; Keith Lillemoe; Elizabeth Mort Journal: Ann Surg Date: 2019-05 Impact factor: 12.969
Authors: Brandon Michael Henry; Matthew J Graves; Jens Vikse; Beatrice Sanna; Przemysław A Pękala; Jerzy A Walocha; Marcin Barczyński; Krzysztof A Tomaszewski Journal: Langenbecks Arch Surg Date: 2017-04-04 Impact factor: 3.445
Authors: Sun Moon Kim; Aimee D Shu; Jin Long; Maria E Montez-Rath; Mary B Leonard; Jeffrey A Norton; Glenn M Chertow Journal: PLoS One Date: 2016-08-16 Impact factor: 3.240